← Back to Search

Radiation Therapy

Prostatectomy for Prostate Cancer

Phase 1

Waitlist Available

Led By Julio Pow-Sang, M.D.

Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 18 months post surgery

Awards & highlights

Study Summary

This trial is testing whether a lower dose of radiation given before surgery is just as effective as the standard dose, with fewer side effects.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 18 months post surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 18 months post surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 18 months post surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Dose Limiting Toxicity

Secondary outcome measures

Mean Catheterization Time for Study Participants

Mean Hospital Stay for Study Participants

Occurrence of Late Toxicity

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dose Escalation of SBRTExperimental Treatment3 Interventions

Stereotactic Body Radiation Therapy (SBRT) followed by prostatectomy and Quality of Life questionnaires. The radiation will be given for only 5 days. Conventional radiation to the prostate is given over 7-8 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Prostatectomy

2014

Completed Phase 2

~1220

Stereotactic Body Radiation Therapy (SBRT)

2018

Completed Phase 2

~740

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor

542 Previous Clinical Trials

135,485 Total Patients Enrolled

27 Trials studying Prostate Cancer

4,177 Patients Enrolled for Prostate Cancer

Julio Pow-Sang, M.D.Principal InvestigatorH. Lee Moffitt Cancer Center and Research Institute

4 Previous Clinical Trials

23 Total Patients Enrolled

4 Trials studying Prostate Cancer

23 Patients Enrolled for Prostate Cancer

Peter Johnstone, M.D.Principal InvestigatorH. Lee Moffitt Cancer Center and Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any federal authorizations for Prostatectomy?

"At this early stage, with limited data on safety and efficacy, our team has assigned Prostatectomy a score of 1."

Answered by AI

Are there any available opportunities to participate in this medical trial?

"Clinicaltrials.gov lists this trial as inactive, with its initial posting date on the 27th of January 2016 and last update occurring 27th September 2022. At present, no participants are being accepted for recruitment yet 1321 other trials presently have open enrolment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

2016. "Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02572284.